Ou Yuan, Zhu Ping
Department of Hematology, The First Hospital of Peking University, Beijing 10034, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1137-40.
Regulatory T cells (Treg) play a key role in the negative regulation of the immune system, which can inhibit inappropriate self-reactive T cells, as well as limit the range, extent and lasting time of immune responses, so as to inhibit the proliferation of CD4(+) and CD8(+) effector T cells. In view of these properties, there is little doubt about the enormous potential value of Tregs in molecular mechanisms and clinical treatment of human autoimmune disorders, graft-versus-host disease (GVHD) and allergies. In this review, the molecular mechanisms of CD4(+)CD25(+) Treg and CD8(+) Treg were mainly discussed, and challenge with which study on Treg cells is faced and prospects were briefly described.
调节性T细胞(Treg)在免疫系统的负调控中起关键作用,它可以抑制不适当的自身反应性T细胞,还能限制免疫反应的范围、程度和持续时间,从而抑制CD4(+)和CD8(+)效应T细胞的增殖。鉴于这些特性,Treg在人类自身免疫性疾病、移植物抗宿主病(GVHD)和过敏症的分子机制及临床治疗方面具有巨大的潜在价值,这一点几乎毋庸置疑。在本综述中,主要讨论了CD4(+)CD25(+) Treg和CD8(+) Treg的分子机制,并简要描述了Treg细胞研究面临的挑战和前景。